Production of the next‐generation positron nuclide zirconium‐89 ( 89 Zr) guided by Monte Carlo simulation and its good quality for antibody labeling
Journal of Labelled Compounds and Radiopharmaceuticals · 2021-01 · 64 (1) · 47-56
DOI: 10.1002/jlcr.3888 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, online erschienen am 30.10.2020. Verfasst von Feng Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer…. Hauptthemen laut MEDLINE: Zirconium, Monte Carlo Method, Radioisotopes, Positron-Emission Tomography. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Beijing Nova Program, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The next‐generation positron zirconium‐89 ( 89 Zr, T 1/2 = 3.27 days) is a novel nuclide for immunological positron emission tomography because of its favorite longer half‐life. The aim of this work is to develop optimized methods for routine production and purification of 89 Zr through Monte Carlo (MC) simulation and laboratory experiments. 89 Y(p,n) 89 Zr reaction was used for 89 Zr production. Optimized thicknesses of Al degrader (0.11 cm) and 89 Y foil (0.064 cm) were simulated through MC method. 89 Zr (15.0–40.7 mCi) with an average production rate of 0.92 ± 0.12 mCi/μA·h was produced after 1‐ to 2‐h bombardment at the proton beam energy of 20 MeV and current of 20 μA. High radio‐purity 89 Zr (6.14–26.8 mCi) obtained eluted from hydroxamate resin using 1‐mol/L oxalic acid solution, with the concentration of 2.7 × 10 4 mCi/L. The gamma spectrum showed that the characteristic peak of 89 Zr was 511 and 909 keV, and no impurities were found. [ 89 Zr]Zr‐DFO‐trastuzumab was successfully labeled and performed good radiochemical purity (>95%) and stability that showed potential application in tumor molecular imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China.
Förderung
- Beijing Nova Program
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Wang, F., Ding, J., Guo, X., Liu, T., Ding, L., Xia, L., Zhu, H., & Yang, Z. (2021). Production of the next‐generation positron nuclide zirconium‐89 ( 89 Zr) guided by Monte Carlo simulation and its good quality for antibody labeling. Journal of Labelled Compounds and Radiopharmaceuticals, 64(1), 47-56. https://doi.org/10.1002/jlcr.3888
Vancouver
Wang F, Ding J, Guo X, Liu T, Ding L, Xia L, et al. Production of the next‐generation positron nuclide zirconium‐89 ( 89 Zr) guided by Monte Carlo simulation and its good quality for antibody labeling. Journal of Labelled Compounds and Radiopharmaceuticals. 2021;64(1):47-56. doi:10.1002/jlcr.3888
BibTeX
@article{Wang2021,
author = {Wang, Feng and Ding, Jin and Guo, Xiaoyi and Liu, Teli and Ding, Lixin and Xia, Lei and Zhu, Hua and Yang, Zhi},
title = {Production of the next‐generation positron nuclide zirconium‐89 ( 89 Zr) guided by Monte Carlo simulation and its good quality for antibody labeling},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2021},
volume = {64},
number = {1},
pages = {47--56},
doi = {10.1002/jlcr.3888}
}
EUVIMED